Quantum technologies exploit the rules of quantum physics to enable new applications and achieve performance beyond the limits of other technologies. They are expected to transform tomorrow’s industry, delivering exponentially faster computers, secure communications, and ultraprecise sensors. A number of countries around the world haves identified them as critical technologies, fundamental to our economic prosperity, social cohesion, and national security.
In parallel, industry activity is growing at an unprecedented rate as evidenced by investments in quantum startups which are tripling year-on-year. Quantum technologies will be especially transformative for biotechnology. They promise revolutionary advances in our ability to observe and model biology across molecular to whole-brain scales. These advances will transform our understanding of the molecular origins of diseases such as cystic fibrosis and Alzheimer’s, deliver disruptive new medical diagnostic and imaging capabilities, and accelerate the development and production of designer drugs, materials, and chemicals.
Can we create a synergistic environment between academia and industry of quantum and biotechnology? Can we create paradigm-shifting quantum technologies to observe biological processes and transform our understanding of life? Can we catalyse an industrial transformation with socioeconomic benefits spanning agriculture, energy, manufacturing, national security, and health? Join this session to hear speakers and the panel discuss the future of quantum biotechnologies and the answers to these and other questions.
Moderator
 |
| |
| |
Halina Rubinsztein-Dunlop
Professor, University of Queensland (Australia)
Deputy Director, QUBIC (Australia) |
|
|
Panelists
 |
| |
| |
Warwick Bowen
Director, Australian Research Council Centre of Excellence in Quantum Biotechnology
University of Queensland (Australia) |
|
|
 |
| |
| |
Celia Merzbacher
Executive Director
QED-C (United States) |
|
|
 |
| |
| |
Geetha Senthil
Deputy Director
Office of Special Initiatives
National Center for Advancing Translational Sciences (NCATS) (United States) |
|
|
 |
| |
| |
Gopal Karemore
Global Quantum Lead in Healthcare and Life Sciences
IBM (United States)
|
|
|
Event Details
FORMAT: Panel discussion followed by audience Q&A.
MENU: Coffee, decaf, and tea will be available nearby.
SETUP: Theater style seating.
